Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 25

CN86 - Advanced breast cancer care for nurses (ABC4Nurses): A mixed-methods evaluation of an online educational programme

Date

21 Oct 2023

Session

Poster session 25

Topics

Tumour Site

Breast Cancer

Presenters

Sarah Sheehan

Citation

Annals of Oncology (2023) 34 (suppl_2): S1229-S1256. 10.1016/annonc/annonc1321

Authors

S. Sheehan1, C. Diez de los Rios de la Serna2, G. Bagcivan3, M. Dowling4, G. Kotronoulas5, A. Shewbridge6, S. Erdem7, V. Aroyo7, B. Radia8, T. Wiseman9, A. Drury1

Author affiliations

  • 1 School Of Nursing, Psychotherapy And Community Health, DCU - Dublin City University, D09 V209 - Dublin/IE
  • 2 N/a, Vall d'Hebron University Hospital, 8035 - Barcelona/ES
  • 3 School Of Nursing, Koc University - School of Nursing, 34010 - Istanbul/TR
  • 4 School Of Nursing And Midwifery, National University of Ireland Galway (NUIG), H91 TK33 - Galway/IE
  • 5 School Of Medicine, Dentistry & Nursing, University of Glasgow, G12 8QQ - Glasgow/GB
  • 6 N/a, Private Practice, London/GB
  • 7 N/a, Europa Donna, Piazza Amendola,/TR
  • 8 N/a, Guy's Cancer Academy - Guy’s Hospital, SE1 9RT - London/GB
  • 9 Applied Health Research, The Royal Marsden Hospital - NHS Foundation Trust, SW3 6JJ - London/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN86

Background

For people living with advanced breast cancer (ABC), specialist nursing is recognised as an essential component of care. However, access to specialist education and training in ABC is limited, contributing to variability in the availability of clinical specialist nurse services throughout Europe. The ABC4Nurses education programme was co-designed with experts by experience and profession in ABC and translated into four European languages following a systematic review and Delphi study to determine priority topics for nurse education in ABC. The aim of this study is to evaluate the implementation and perceived impact of the education programme from the perspectives of nurses who have completed the programme.

Methods

A mixed-methods evaluation was undertaken, guided by the Kirkpatrick framework (1967). Questionnaires were administered prior to commencing the programme to evaluate expectations for the programme (T1), and immediately after completion of the programme (T2) to assess overall satisfaction and personal views of the programme. Semi-structured qualitative interviews were held with a smaller number of participants to explore the perceived impact of the programme on ABC care in the participants’ place of work.

Results

Of 655 registered participants, 188 (29%) participated in T1, and to date, 53 (30%) of these participants have completed all 6 modules, and the T2 questionnaire. T1 participants (n=188) were from the UK (27%), Spain (26%), Turkey (18%) and the Czech Republic (13%). ABC4Nurses has been evaluated positively by T2 participants (n=53), with 94% reporting that the programme has helped them in their work and would recommend this programme to their co-workers. On average, participants felt prepared to care for people with ABC (Mean: 8.2, SD: 1.5) and were committed to applying learning from the programme in their roles (Mean: 9.1, SD: 1.6).

Conclusions

This study shows that a novel, co-designed online learning programme in ABC was effective in enhancing cancer nurses’ confidence and commitment to the delivery of care to people living with ABC. Furthermore, the results demonstrate the potential reach of the programme as a result of the programme being available in an accessible, translated format.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Dublin City University.

Funding

Pfizer.

Disclosure

T. Wiseman, A. Drury: Financial Interests, Institutional, Funding: EONS/Pfizer. All other authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.